Integrative data-intensive approaches to drug design
The 23rd EuroQSAR Symposium will take place in Heidelberg, chaired by HITS group leader Rebecca Wade. Deadline for abstract submission: 4 August 2022
From 26-30 September 2022, the 23rd European Symposium on Quantitative Structure-Activity Relationship (QSAR) will take place in Heidelberg. It is entitled “Integrative Data-Intensive Approaches to Drug Design” and chaired by HITS group leader Rebecca Wade (MCM).
The scientific programme of the Symposium will include 12 plenary lectures, 20 session lectures, 7 oral communications, company workshops, poster presentations and a commercial exhibition.
The submission deadline for poster presentations is 4 August 2022.
The EuroQSAR Symposia have been taking place since 1973 and constitute major scientific events in the field of computational drug design, with further applications in agricultural and environmental sciences.
About HITS
HITS, the Heidelberg Institute for Theoretical Studies, was established in 2010 by physicist and SAP co-founder Klaus Tschira (1940-2015) and the Klaus Tschira Foundation as a private, non-profit research institute. HITS conducts basic research in the natural, mathematical, and computer sciences. Major research directions include complex simulations across scales, making sense of data, and enabling science via computational research. Application areas range from molecular biology to astrophysics. An essential characteristic of the Institute is interdisciplinarity, implemented in numerous cross-group and cross-disciplinary projects. The base funding of HITS is provided by the Klaus Tschira Foundation.
powered by Borlabs Cookie